Brandywine Global Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186K | Hold |
39,390
| – | – | ﹤0.01% | 564 |
|
|
2025
Q1 | $181K | Hold |
39,390
| – | – | ﹤0.01% | 548 |
|
|
2024
Q4 | $189K | Buy |
39,390
+4,820
| +14% | +$23.1K | ﹤0.01% | 547 |
|
|
2024
Q3 | $166K | Buy |
+34,570
| New | +$166K | ﹤0.01% | 652 |
|
|
2023
Q1 | – | Sell |
-148,219
| Closed | -$1.1M | – | 771 |
|
|
2022
Q4 | $1.1M | Buy |
+148,219
| New | +$1.1M | 0.01% | 634 |
|
|
2018
Q4 | – | Sell |
-47,353
| Closed | -$1.09M | – | 898 |
|
|
2018
Q3 | $1.09M | Buy |
47,353
+71
| +0.2% | +$1.63K | 0.01% | 562 |
|
|
2018
Q2 | $901K | Sell |
47,282
-1,117
| -2% | -$21.3K | 0.01% | 590 |
|
|
2018
Q1 | $816K | Buy |
+48,399
| New | +$816K | 0.01% | 589 |
|